Monthly Archives: April 2013

Targeted Medical Pharma Pre-announces 2013 Unaudited Q1 Revenue

–Company Reports Five Consecutive Quarters of Growth–   Los Angeles, April 23, 2013, Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced unaudited revenue of $2,811,000 for the first quarter ended on March 31, 2013, a 104% increase from the $1,375,000 reported for the same period of the prior year and increased from $2,396,000 of the fourth quarter of 2012. “We continued to experience steady growth of new markets nationally, and an Continue reading →

Targeted Medical Pharma Announces Registration Statement

Los Angeles, April 18, 2013 – Targeted Medical Pharma, Inc. (OTCQB: TRGM) (the “Company”), a biotechnology company that develops and distributes prescription medical foods to physicians and pharmacies, today announced that its Form S-1 registration statement (the “Registration Statement”), which registers up to 25,723,395 shares of common stock (“Shares”) for resale by selling stockholders on a delayed or continuous basis, has cleared comments with the United States Securities and Exchange Commission and accordingly, the Company has requested the Registration Statement be declared effective at 4:00 Continue reading →

Targeted Medical Pharma to Present at American Medical Society for Sports Medicine

Los Angeles, April 15, 2013, Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, will present clinical information on the benefits of Theramine® at the American Medical Society for Sports Medicine’s (AMSSM) 22nd Annual Meeting, April 17-21, at the Manchester Grand Hyatt in San Diego. The five-day conference is designed to provide regional, national and international perspectives on a broad range of sports medicine topics, including sessions on extremity Continue reading →

Targeted Medical Pharma Appoints Dr. David Silver as President and COO

Los Angeles, April 3, 2013, Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today announced the promotion of David Silver, M.D., to the newly created position of president and chief operating officer, where he will oversee the company’s expansion efforts and daily operations, while continuing his responsibilities as executive vice president of medical and scientific affairs. “Dr. Silver has been an integral part of our organization since giving Continue reading →

Targeted Medical Pharma Reports 2012 Results

  –Company to Focus on Marketing/Sales; Expanding Product Pipeline in 2013– Los Angeles, CA April 1, 2013, Targeted Medical Pharma, Inc. (OTCQB: TRGM), a biotechnology company that develops and distributes prescription medical foods, convenience kits and generic pharmaceuticals to physicians and pharmacies, today filed its 10-K and announced the Company’s 2012 financial results. “We are pleased to report that the second half of 2012 has come back strong and clearly reflects the traction we are seeing as we continue to gain momentum,” said Chief Executive Continue reading →